8/31/2005

The FDA is succumbing to political pressure and backing out on a promise to make a decision whether to approve over-the-counter dispensing of the morning-after pill, the Boston Globe says. OTC approval without imposing age restrictions would reduce the country's abortion rate, the paper contends.

Related Summaries